NTRA
Natera Inc
NASDAQ: NTRA · HEALTHCARE · DIAGNOSTICS & RESEARCH
$194.75
-2.71% today
Updated 2026-04-29
Market cap
$27.81B
P/E ratio
—
P/S ratio
12.06x
EPS (TTM)
$-1.52
Dividend yield
—
52W range
$132 – $256
Volume
1.3M
Natera Inc (NTRA) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14.25M | $55.17M | $159.29M | $190.35M | $217.07M | $210.94M | $257.65M | $302.33M | $391.00M | $625.49M | $820.22M | $1.08B | $1.70B | $2.31B |
| Revenue growth (YoY) | — | +287.2% | +188.7% | +19.5% | +14.0% | -2.8% | +22.1% | +17.3% | +29.3% | +60.0% | +31.1% | +32.0% | +56.7% | +35.9% |
| Cost of revenue | $11.15M | $37.27M | $78.40M | $112.84M | $135.57M | $139.60M | $166.06M | $175.47M | $203.62M | $318.42M | $456.26M | $589.83M | $673.75M | $810.63M |
| Gross profit | $3.10M | $17.90M | $80.89M | $77.51M | $81.50M | $71.34M | $91.60M | $126.86M | $187.38M | $307.07M | $363.97M | $492.74M | $1.02B | $1.50B |
| Gross margin | 21.7% | 32.4% | 50.8% | 40.7% | 37.5% | 33.8% | 35.6% | 42.0% | 47.9% | 49.1% | 44.4% | 45.5% | 60.3% | 64.8% |
| R&D | $6.98M | $11.55M | $17.29M | $27.71M | $41.86M | $50.06M | $51.35M | $51.36M | $100.03M | $264.21M | $316.42M | $320.68M | $404.14M | $624.11M |
| SG&A | $15.13M | $31.21M | $61.84M | $109.64M | $136.13M | $155.31M | $154.87M | $206.18M | $303.63M | $511.03M | $588.59M | $618.31M | $841.31M | $1.18B |
| Operating income | $-19.21M | $-25.27M | $665000.00 | $-59.84M | $-96.49M | $-134.03M | $-114.63M | $-116.29M | $-216.28M | $-468.17M | $-541.04M | $-446.25M | $-222.29M | $-309.91M |
| Operating margin | -134.8% | -45.8% | 0.4% | -31.4% | -44.4% | -63.5% | -44.5% | -38.5% | -55.3% | -74.8% | -66.0% | -41.2% | -13.1% | -13.4% |
| EBITDA | $-18.49M | $-22.74M | $4.21M | $-61.23M | $-93.37M | $-125.82M | $-107.13M | $-104.41M | $-205.95M | $-451.54M | $-507.03M | $-383.28M | $-148.08M | $-264.02M |
| EBITDA margin | -129.8% | -41.2% | 2.6% | -32.2% | -43.0% | -59.6% | -41.6% | -34.5% | -52.7% | -72.2% | -61.8% | -35.4% | -8.7% | -11.4% |
| EBIT | $-19.21M | $-25.27M | $-933000.00 | $-66.77M | $-99.55M | $-132.96M | $-114.63M | $-112.14M | $-214.56M | $-462.79M | $-537.50M | $-421.89M | $-179.05M | — |
| Interest expense | — | $11.94M | $4.22M | $3.50M | $533000.00 | $4.21M | $10.48M | $10.69M | $15.08M | $8.30M | $9.32M | $12.64M | $10.69M | $4.07M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-76.17M | $-37.11M | $-5.15M | $-70.28M | $-95.77M | $-136.31M | $-128.15M | $-124.83M | $-229.74M | $-471.72M | $-547.80M | $-434.80M | $-190.43M | $-208.16M |
| Net income growth (YoY) | — | +51.3% | +86.1% | -1264.0% | -36.3% | -42.3% | +6.0% | +2.6% | -84.0% | -105.3% | -16.1% | +20.6% | +56.2% | -9.3% |
| Profit margin | -534.5% | -67.3% | -3.2% | -36.9% | -44.1% | -64.6% | -49.7% | -41.3% | -58.8% | -75.4% | -66.8% | -40.2% | -11.2% | -9.0% |